Immune12 is currently produced for laboratory and trial use only. It is a proprietary complex biologic derived from specific marine-sourced ingredients that may have potential anti-cancer properties based on preclinical studies and limited early phase human trials. Features of Immune-12 which align to it becoming a revolutionary treatment include the:

• Observed effectiveness which is exceeding the current standard of care (SOC) expectations.
• Non-toxicity with low negative side effects, especially as compared to the current SOC.
• Ability to administer in any environment, even at home.